[Results of a multidisciplinary treatment protocol for advanced squamous cell carcinoma in the ORL region].

Hausmaninger, H; Gruber, W; Plewka, J; Salis-Samaden, R; Laryngol Rhinol Otol (Stuttg). 1983; 62(9): 431-435.

[Mitoxantrone in a combination regimen in advanced breast cancer].

Hausmaninger, H; Wien Med Wochenschr. 1985; 135(23-24): 594-597.

[Infiltration pattern of immunocompetent lymphocytes in the tissue of malignant non-Hodgkin“s lymphoma: relationship to histological and clinical parameters].

Gattringer, C; Radaszkiewicz, T; Greil, R; Pfaller, W; Huber, H; Wien Klin Wochenschr. 1985; 97(5):258-263

[Rhabdomyolysis as a late complication of anesthesia–a case of malignant hyperthermia?].

Greil, R; Gattringer, C; Abbrederis, K; Wien Klin Wochenschr. 1985; 97(21):813-816

Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.

Greil, R; Gattringer, C; Schulz, T; Knapp, W; Radaskiewicz, T; Dierich, MP; Huber, H; Clin Exp Immunol. 1986; 64(2):42-31

In situ quantification of T-cell subsets, NK-like cells and macrophages in Hodgkin“s disease: quantity and quality of infiltration density depends on histopathological subtypes.

Gattringer, G; Greil, R; Radaszkiewicz, T; Huber, H; Blut. 1986; 53(1): 49-58.

Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomas.

Greil, R; Gattringer, C; Knapp, W; Huber, H; Br J Haematol. 1986; 62(2): 29-300.

[Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].

Huber, H; Thaler, J; Greil, R; Gattringer, C; Radaszkiewicz, T; Onkologie. 1986; 9(2): 108-113.

Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia

Hoelzer, D; Thiel, E; Löffler, H; Büchner, T; Ganser, A; Heil, G; Kurrle, E; Heimpel, H; Koch, P; Lipp, T; Kaboth, W; Kuse, R; Küchler, R; Sodomann, H; Maschmeyer, G; Freund, M; Diedrich, H; von Paleske, A; Weh, J; Kolb, H, Müller, U; Bross, K; Fuhr, G; Gassmann, W; Gerecke, D; Kress, M; Busch, FW; Nowrousian, RM; Schneider, W; Aul, C; Rühl, H; Bartels, H; Harms, F; Weiss, A; Löffler, B; Glöckner, W; Fülle, H; Pralle, H; Ho, AD; Bonfert, B; Emmerich, B; Braumann, D; Brenner-Serke, M; Planker, M; Straif, K; Meyer, P; Greil, R; Petsch, S; Görg, C; Grüneisen, A; Vaupel, HA; Bodenstein, H; Overkamp, F; Schlimock, G; Augener, W; Ohl, S; Nowicki, L; Raeth, U; Zurborn, KH; Neiss, A; Messerer, D; Semin Oncol, Suppl 1. 1987. 14: 92-97.

Combination chemotherapy with aclarubicin in metastatic breast cancer.

Simader, H; Hausmaninger, H; Fereberger, W; Samonigg, H; Eur J Haematol Suppl. 1987; 47: 71-76.